Back to mobile site

Medtronic acquires SPR Therapeutics for $650 million

July 16, 2026 9:01 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) announced it has completed the acquisition of SPR Therapeutics, Inc., a privately held medical technology company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login